Moneycontrol PRO
HomeNewsWorldExposure to SARS, other coronaviruses may make some people immune to COVID-19: Report

Exposure to SARS, other coronaviruses may make some people immune to COVID-19: Report

Experts are not surprised as an average of 20 percent common cold cases are due to coronaviruses, which means they are already widespread among humans.

July 19, 2020 / 14:42 IST
Representative Image (AP Photo/Mahesh Kumar A.)

A study by Singapore-based researchers have found that some individuals may have developed immunity to the novel coronavirus – scientific name SARS-CoV-2 – due to exposure to other coronaviruses.

As per the study, published in Nature journal on July 15,  a few people may have developed an immunity to COVID-19 even without being exposed to it due to having been previously infected by other coronaviruses, as per a Hindustan Times report.

According to the study, some individuals have T-cells,  the type of white blood cells that recognise the virus’ two proteins – structural or nucleocapsid proteins and non-structural viral proteins (NSP). T-cells typically detect viruses/infections in the immune system.

“We characterised Sars-CoV-2 specific T-cells in COVID-19 and SARS (the 2003 outbreak) convalescents and uninfected healthy individuals,” Dr Antonio Bertolleti, study co-author and professor of emerging infectious diseases at Duke-Nus Medical School in Singapore told the paper.

Dr Bertolleti added that individuals who recovered from COVID-19 possessed T-cells structural proteins more efficiently than NSPs and had also been infected with SARS – which they also recovered from, thus suggesting cross-reactive cellular immunity.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The development is significant as it may give scientists more clues in building a vaccine against COVID-19, as those with immunity generate neutralising antibodies. After reviewing the paper, drug developer Derek Lowe said T-cell immunity may drive vaccine development against COVID-19, it added.

Follow our LIVE Updates on the coronavirus pandemic here

The study found that over 50 percent of COVID-19 negative individuals demonstrate T-cells equipped to detect SARS-CoV-2 and these cells “recognised more frequently sequences of non-structural proteins found only in animal coronaviruses.”

Thus, a large part of the population possesses Sars-Cov2-specific T cells, likely induced by other coronaviruses. “One possible implication of our findings is that many subjects might have a level of progress T-cell reactivity that might partially protect them,” he added.

Experts however are not surprised as an average of 20 percent common cold cases are due to coronaviruses, which means they are already widespread among humans. For reference, SARS-CoV-2 shares 80 percent sequence identity with SARS and 50 percent with other coronaviruses, Shahid Jameel, virologist and CEO of Wellcome Trust/DBT India Alliance noted.

Notably, India was largely spared from the SARS outbreak in 2003, so how much of the population could have immunity is debatable.

Follow our full COVID-19 coverage here

Moneycontrol News
first published: Jul 19, 2020 02:42 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347